As a trade group for endovascular specialists, VIVA has been at the ground level for the controversy around the safety of paclitaxel-coated balloons and stents in treating patients with peripheral artery disease (PAD).
And now that the concerns have been put to rest, VIVA physicians are coming together to discuss what they’ve learned...